The Global Immunohistochemistry Market Anticipated to Expand at a CAGR of Around 7.64% by 2030 | DelveInsight

(Albany, USA) DelveInsight's Immunohistochemistry Market Insights report provides the current and forecast market, forthcoming device innovation, individual leading companies' market shares, challenges, immunohistochemistry market drivers, barriers, and trends, and key immunohistochemistry companies in the market.
The immunohistochemistry market is anticipated to grow due to the rise in cases of chronic and infectious diseases such as cancer, and herpes virus infection, among others, and the rising implementation of automation and machine learning concepts in the field of IHC are the factors expected to spur the immunohistochemistry market in the upcoming years.

Request for sample report @ Immunohistochemistry Market Insights - https://www.delveinsight.com/report-store/immunohistochemistry-ihc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Key Takeaways from the Immunohistochemistry Market Report
• As per DelveInsight analysis, North America is anticipated to dominate the global immunohistochemistry market during the forecast period.
• Leading immunohistochemistry companies such as Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, PerkinElmer Inc., Danaher Corporation, Merck KGaA, Bio-Techne., Genemed Biotechnologies, Inc., Abcam plc, Becton, Dickinson and Company, Bio SB, Inc., BioGenex., Biocare Medical, LLC., Diagnostic BioSystems Inc., ROCKLAND IMMUNOCHEMICALS, INC., Elabscience Biotechnology Inc., Sakura Finetek USA, Inc., CANDOR Bioscience GmbH, NeoGenomics Laboratories, and several others are currently dominating the immunohistochemistry market.
• In April 2025, Roche's VENTANA TROP2 RxDx Device was granted FDA Breakthrough Device Designation. This AI-powered diagnostic tool aims to assist in treatment decisions for patients with non-small cell lung cancer (NSCLC). By combining an immunohistochemistry test with AI technology, the device helps improve the accuracy of diagnoses and patient selection for targeted treatments.
• In November 2024, the U.S. Food and Drug Administration (FDA) approved zanidatamab (brand name Ziihera) for adults with HER2-positive (IHC 3+) biliary tract cancer that has not been surgically removed or has spread to other areas, and who have previously undergone treatment. This approval highlights the importance of immunohistochemistry (IHC) in identifying patients with HER2 overexpression, specifically those with IHC 3+ results, who can benefit from targeted therapies. It further emphasizes the growing role of IHC in personalized cancer treatment.
• In December 2023, Biocare Medical introduced the intelliPATH+ Advanced Staining Instrument, an upgrade to their intelliPATH FLX system. This new platform enhances IHC staining automation, offering features like continuous random access and STAT capabilities, which streamline processes and improve efficiency in diagnostic workflows. This advancement supports the growing demand for precise immunohistochemistry solutions in clinical and research settings.
• On July 20, 2021, Agilent Technologies Inc.'s PD-L1 IHC 22C3 pharmDx assay was labeled for expanded use in patients with non-small cell lung cancer (NSCLC) in the European Union.
• On April 23, 2021, Roche received FDA approval for the VENTANA MMR RxDx Panel, the first immunohistochemistry predictive test in endometrial cancer for treatment with the anti-PD1 immunotherapy JEMPERLI (dostarlimab-gxly).
• Thus, owing to such developments in the market, rapid growth will be observed in the immunohistochemistry market during the forecast period.

To read more about the latest highlights related to immunohistochemistry, get a snapshot of the key highlights entailed in the Global Immunohistochemistry Market Report - https://www.delveinsight.com/sample-request/immunohistochemistry-ihc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Immunohistochemistry (IHC) Overview
Immunohistochemistry (IHC) is a technique that combines anatomical, immunological and biochemical techniques to image discrete components in tissues by using appropriately-labeled antibodies to bind specifically to their target antigens in situ. Immunohistochemistry is an important application of monoclonal and polyclonal antibodies to determine the tissue distribution of an antigen of interest in health and disease. IHC is widely used for the diagnosis of cancers; specific tumor antigens are expressed de novo or up-regulated in certain cancers.
One of the noteworthy factors raising the demand for immunohistochemistry techniques is the surge in various infectious diseases among the population across the globe. This is because the IHC technique uses specific antibodies to viral, bacterial, fungal, and parasitic antigens to detect and identify the causative agents in many infectious diseases.

Immunohistochemistry Market Insights
Geographically, the global immunohistochemistry market is studied in North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share, North America currently leads the global market and is projected to hold its immunohistochemistry market position during the study period. This domination is owing to the surge in the new cancer cases in the region.
In addition, the approval of various IHC products as companion diagnostic for cancer in the region would also raise the immunohistochemistry market in the upcoming years.

To know more about why North America is leading the market growth in the immunohistochemistry market, get a snapshot of the Immunohistochemistry Market Trends - https://www.delveinsight.com/report-store/immunohistochemistry-ihc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Immunohistochemistry Market Dynamics
The global immunohistochemistry market is anticipated to witness considerable growth owing to the rise in approval and launch of various technologically advanced IHC products. Also, the increase in research and development activities and advancements in IHC protocols have boosted its demand to a significant level in disease diagnosis.
However, certain factors such as the risk of false-positive results and the high cost of the instruments are likely to impede the immunohistochemistry market growth.
Additionally, the unprecedented COVID-19 pandemic has slowed down the immunohistochemistry market. This is due to the temporary halt in manufacturing facilities, reduction in the screening process of various diseases such as cancer, and others due to the imposition of lockdown restrictions across the globe. However, the pandemic has also provided opportunities for IHC product manufacturers as they have undertaken initiatives to overcome the challenges posed by this pandemic and shifted their business focus by introducing IHC products for COVID-19 research. For instance, Bio SB, a US-based company, has developed and manufactured the CoV-2 recombinant proteins and peptides needed to generate antibodies to identify the virus, receptors, and ILs by Immunohistochemistry and Immunofluorescence on FFPE biopsies.

Get a sneak peek at the immunohistochemistry market dynamics @ Immunohistochemistry Market Dynamics Analysis - https://www.delveinsight.com/sample-request/immunohistochemistry-ihc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Immunohistochemistry Market Report
• Coverage: Global
• Study Period: 2021-2030
• Market Segmentation By Product Type: Instruments, Reagents & Kits, Services
• Market Segmentation By Application: Diagnostic, Research, Others
• Market Segmentation By End User: Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Others
• Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Key Immunohistochemistry Companies: Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, PerkinElmer Inc., Danaher Corporation, Merck KGaA, Bio-Techne., Genemed Biotechnologies, Inc., Abcam plc, Becton, Dickinson and Company, Bio SB, Inc., BioGenex., Biocare Medical, LLC., Diagnostic BioSystems Inc., ROCKLAND IMMUNOCHEMICALS, INC., Elabscience Biotechnology Inc., Sakura Finetek USA, Inc., CANDOR Bioscience GmbH, NeoGenomics Laboratories, among others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

DelveInsight Analysis: The immunohistochemistry market size is expected to grow at a CAGR of 7.64% to reach about USD 3.98 billion by 2030.

Which MedTech key players in the immunohistochemistry market are set to emerge as the trendsetter explore @ Immunohistochemistry Companies - https://www.delveinsight.com/sample-request/immunohistochemistry-ihc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents
1. Report Introduction
2. Executive summary
3. Regulatory and Patent Analysis
4. Key Factors Analysis
5. Porter's Five Forces Analysis
6. COVID-19 Impact Analysis on Immunohistochemistry Market
7. Immunohistochemistry Market Layout
8. Global Company Share Analysis - Key 3-5 Companies
9. Immunohistochemistry Market Company and Product Profiles
10. Project Approach
11. About DelveInsight

Interested in knowing the immunohistochemistry market by 2030? Click to get a snapshot of the Immunohistochemistry Test - https://www.delveinsight.com/sample-request/immunohistochemistry-ihc-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Trending Report:
• Ventricular Fibrillation Market: https://www.delveinsight.com/report-store/electrophysiology-devices-market
• Cardiotoxicity Market: https://www.delveinsight.com/report-store/cardiotoxicity-epidemiology-forecast
• Healthcare Subscription Models: https://www.delveinsight.com/blog/subscription-model-in-healthcare
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Healthcare Competitive Benchmarking: https://www.delveinsight.com/consulting/competitive-benchmarking-services
• Wound Irrigation Systems Market: https://www.delveinsight.com/report-store/wound-irrigation-systems-market
• Pulse Oximeter Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Central Venous Catheters Market: https://www.delveinsight.com/report-store/central-venous-catheters-market
• Hearing Implants Market: https://www.delveinsight.com/report-store/hearing-implants-market
• Apheresis Market: https://www.delveinsight.com/report-store/apheresis-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Gaucher Disease Market: https://www.delveinsight.com/report-store/gauchers-disease-market
• Menopause Market: https://www.delveinsight.com/report-store/menopause-market
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Healthcare Due Diligence Services: https://www.delveinsight.com/consulting/due-diligence-services
• Anti-cd274 Pd-l1 Antibody Pipeline: https://www.delveinsight.com/report-store/pd-1-and-pd-l1-inhibitors-competitive-landscape
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Vertigo Market: https://www.delveinsight.com/report-store/vertigo-market
• Calcinosis Cutis Market: https://www.delveinsight.com/report-store/calcinosis-cutis-market
• Healthcare Consulting: https://www.delveinsight.com/consulting
• Healthcare Partner Identification Services: https://www.delveinsight.com/consulting/partner-identification-services
• Molecular Glue Market: https://www.delveinsight.com/report-store/molecular-glues-market-forecast
• Trigeminal Neuralgia Market Size: https://www.delveinsight.com/report-store/trigeminal-neuralgia-market

Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

This release was published on openPR.